Matches in Wikidata for { <http://www.wikidata.org/entity/Q91418630> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91418630 description "article scientifique publié en 2019" @default.
- Q91418630 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91418630 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91418630 description "scientific article published on 25 November 2019" @default.
- Q91418630 description "wetenschappelijk artikel" @default.
- Q91418630 description "наукова стаття, опублікована 25 листопада 2019" @default.
- Q91418630 name "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 name "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 type Item @default.
- Q91418630 label "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 label "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 prefLabel "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 prefLabel "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 P1433 Q91418630-3C02DFE4-6907-49FE-8F6D-17EA4EB8D6A1 @default.
- Q91418630 P1476 Q91418630-29963916-764B-4039-8E18-7EB69A92D378 @default.
- Q91418630 P2093 Q91418630-A6A9489E-BAD0-47EA-8A93-258410CFB4CF @default.
- Q91418630 P2093 Q91418630-C24E5A14-0205-40F7-8C20-6D2614FE28E9 @default.
- Q91418630 P2093 Q91418630-CF48DB5F-8BB4-4EE9-95A2-CE1AB92413B9 @default.
- Q91418630 P2093 Q91418630-D70419FC-3D9F-40D1-94E0-0B8537097D4C @default.
- Q91418630 P304 Q91418630-54B3CADC-8DB0-4549-9390-3FDB33FC37EE @default.
- Q91418630 P31 Q91418630-62385F79-CC4A-443A-B266-A0A84FEE5F50 @default.
- Q91418630 P356 Q91418630-E7C81CFD-CE93-43FD-993D-C4BA9D6580D9 @default.
- Q91418630 P433 Q91418630-EE311099-BF06-4A71-BAAE-0B9273128166 @default.
- Q91418630 P478 Q91418630-0ABC423A-EC05-4EEF-806B-0DED4C7B1D2D @default.
- Q91418630 P50 Q91418630-31C75A2A-BA2A-4296-A28D-818DE4A458E6 @default.
- Q91418630 P50 Q91418630-3775EAD6-9A24-45B5-A96A-C988E6F8CBD5 @default.
- Q91418630 P50 Q91418630-48EBA95F-5502-4D4C-967F-C70DC7B4621C @default.
- Q91418630 P577 Q91418630-05CD2A80-7380-4F04-A821-DA20412BC355 @default.
- Q91418630 P698 Q91418630-2A674051-01E1-4B0C-8145-9735A32C2CE8 @default.
- Q91418630 P356 23744235.2019.1694696 @default.
- Q91418630 P698 31760833 @default.
- Q91418630 P1433 Q27726222 @default.
- Q91418630 P1476 "Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy" @default.
- Q91418630 P2093 "BIRDi study group" @default.
- Q91418630 P2093 "José L Blanco" @default.
- Q91418630 P2093 "Nuria Espinosa" @default.
- Q91418630 P2093 "Rocío Montejano" @default.
- Q91418630 P304 "202-206" @default.
- Q91418630 P31 Q13442814 @default.
- Q91418630 P356 "10.1080/23744235.2019.1694696" @default.
- Q91418630 P433 "3" @default.
- Q91418630 P478 "52" @default.
- Q91418630 P50 Q47006508 @default.
- Q91418630 P50 Q87367413 @default.
- Q91418630 P50 Q91418625 @default.
- Q91418630 P577 "2019-11-25T00:00:00Z" @default.
- Q91418630 P698 "31760833" @default.